ENFAGROW 4 PREMIUM 1100G+BSA GTIS PARAFINA LIQ Adalimumab 40 mg

Description

Adalimumab 40 mg

FORMA FARMACÉUTICA: 3 TABLETAS

PRINCIPIO ACTIVO: DIFENHIDRAMINA

TALTZ® 80 mg/mL es un medicamento biotecnológico de administración subcutánea que contiene Ixekizumab

PRINCIPIO ACTIVO: DICLORHIDRATO DE TRIMETAZIDINA

ENFAGROW 4 PREMIUM 1100G+BSA GTIS PARAFINA LIQ Adalimumab 40 mgPRINCIPIO ACTIVO: NA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy